Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04153071

Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study

Evaluation of the Cutaneous Effects of a Unipolar Microplasma Electrode Pin Radiofrequency Device: An In-vivo Histologic Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Alma Lasers · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Prospective, Open-Label, Single-Center Pilot Study. The study is aimed to evaluate the histologic effects of a unipolar microplasma electrode pin radiofrequency device (Alma Lasers OPUS system) on the abdominal skin. The study will include up to 2 subjects. Each subject will have a single cutaneous treatment of their lower abdomen, with variable treatment parameters. Punch biopsies will be obtained from each treatment section, for in-vivo histological evaluations.

Conditions

Interventions

TypeNameDescription
DEVICEOPUS systemEach subject will have a single cutaneous treatment of their lower abdomen, with variable treatment parameters. Punch biopsies will be obtained from each treatment section, for in-vivo histological evaluations.

Timeline

Start date
2019-10-23
Primary completion
2020-09-16
Completion
2020-09-16
First posted
2019-11-06
Last updated
2020-09-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04153071. Inclusion in this directory is not an endorsement.

Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study (NCT04153071) · Clinical Trials Directory